Stereotaxis, Inc. (NASDAQ:STXS)

CAPS Rating: 3 out of 5

The Company designs, manufactures and markets an advanced cardiology instrument control system for use in a hospital's interventional surgical suite, or cath lab.

Recs

0
Player Avatar KimLanners (< 20) Submitted: 5/3/2011 4:10:27 PM : Outperform Start Price: $3.40 STXS Score: -88.84

cheap medical

Featured Broker Partners


Advertisement